These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15607618)

  • 1. The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men.
    Fleischmann EH; John S; Delles C; Schneider MP; Schmidt BM; Schmieder RE
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1120-6. PubMed ID: 15607618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.
    Fogari R; Zoppi A; Mugellini A; Maffioli P; Lazzari P; Derosa G
    Hypertens Res; 2011 Dec; 34(12):1321-6. PubMed ID: 21814211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
    Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
    Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients.
    Sim JS; Dick JB; Struthers AD
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):109-13. PubMed ID: 15526245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
    Willemsen JM; Rabelink TJ; Boer P; Gaillard CA
    J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors.
    Phoon S; Howes LG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):36-9. PubMed ID: 11984746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
    Kanome T; Watanabe T; Nishio K; Takahashi K; Hongo S; Miyazaki A
    Hypertens Res; 2008 Sep; 31(9):1801-10. PubMed ID: 18971559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D; Lowy A; Howes JB; Howes LG
    Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
    Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension.
    Sasamura H; Kitamura Y; Nakamura M; Ryuzaki M; Saruta T
    Clin Exp Hypertens; 2006 Jul; 28(5):511-20. PubMed ID: 16820347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of advanced glycation end products by candesartan in patients with diabetic kidney disease--a dose-response relationship study.
    Saha SA; LaSalle BK; Clifton GD; Short RA; Tuttle KR
    Am J Ther; 2010; 17(6):553-8. PubMed ID: 19829095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients.
    Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Seo YH; Kang MH; Ahn TH; Choi IS; Shin EK
    Circulation; 2004 Dec; 110(24):3687-92. PubMed ID: 15569835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin.
    van der Linde NA; Sijbrands EJ; Boomsma F; van den Meiracker AH
    Hypertension; 2006 Jun; 47(6):1125-30. PubMed ID: 16618834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.